Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society

Nonalcoholic fatty liver disease (NAFLD) is a pathogenetically complex and clinically heterogeneous disease resulting from a diverse interaction of environmental components and a genetic background. It is a systemic condition featuring metabolic, cardiovascular, and (both hepatic and extrahepatic) cancer risk [1,2]. NAFLD is not only a sequelae of diabetes mellitus, obesity, and the metabolic syndrome, but itself is a determinant for the future development of type 2 diabetes mellitus and the metabolic syndrome which has potentially relevant clinical implications for diagnosing, preventing, and treating these conditions [3,4].
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Tags: Correspondence Source Type: research